Records 1 - 6
| CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole.
Pharmacogenomics and personalized medicine 2018 11 107-112.
Denisenko Natalia P, Sychev Dmitriy A, Sizova Zhanna M, Smirnov Valeriy V, Ryzhikova Kristina A, Sozaeva Zhannet A, Grishina Elena
| Modeling the cost-effectiveness of ilaprazole versus omeprazole for the treatment of newly diagnosed duodenal ulcer patients in China.
Journal of medical economics 2016 Nov 19 (11): 1056-1060.
Xuan J W, Song R L, Xu G X, Lu W Q, Lu Y J, Liu
| Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial.
Current medical research and opinion 2012 Jan 28 (1): 101-9.
Wang Ling, Zhou Liya, Hu Haitang, Lin Sanren, Xia Jiel
| Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
Pharmacotherapy 2011 Mar 31 (3): 227-38.
Yang Jyh-Chin, Wang Hong-Long, Chern Herng-Der, Shun Chia-Tung, Lin Bor-Ru, Lin Chun-Jung, Wang Teh-Ho
| Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype.
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2003 Dec 42 (6): 468-75.
Lee Sang Bae, Park Sang Jong, Ryu Ji Kon, Lee Jin Kwang, Kim Hoi Jin, Bae Jin Soo, Jung Hyun Seung, Park Sil M
| [The effect of proton pump inhibitor on intragastric acidity and it relation to S-mephenytoin hydroxylase genetic polymorphism].
Zhonghua nei ke za zhi 2003 Nov 42 (11): 777-80.
Wang Hong, Nie Yu-qiang, Dai Shou-jun, She Qing-zhu, Li Yu-yu